Document is current
Any future updates will be listed below
-
Authors
Khan, Muhammad Shahzeb
Shahid, Izza
Bennis, Ahmed http://orcid.org/0000-0002-0667-1142
Rakisheva, Amina
Metra, Marco http://orcid.org/0000-0001-6691-8568
Butler, Javed http://orcid.org/0000-0001-7683-4720
- License Information
-
More Information
Article History
Accepted: 28 May 2024
First Online: 26 June 2024
Competing interests
: M.S.K. has received fees from Bayer. A.B. has received institutional fees from Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Merck, Novartis and Servier. A.R. has received speaker honoraria from AstraZeneca, Novartis and Roche. M.M. has received consulting honoraria for participation in steering committees or advisory boards or for speeches from Abbott Vascular, Amgen, AstraZeneca, Bayer, Edwards Lifesciences, Fresenius, Novartis and Servier. J.B. reports consulting fees from Boehringer Ingelheim, Cardior, CVRx, Foundry, G3 Pharma, Imbria, Impulse Dynamics, Innolife, Janssen, LivaNova, Luitpold, Medtronic, Merck, Novartis, NovoNordisk, Relypsa, Roche, Sanofi, Sequana Medical, V-Wave Ltd and Vifor. I.S. declares no competing interests.
